Min Peng
- Cancer Research top 2%
- MicroRNA in disease regulation 6
- Immunology top 2%
- Immune Cell Function and Interaction 11
- T-cell and B-cell Immunology 7
- Molecular Biology top 2%
- DNA Repair Mechanisms 14
- Mitochondrial Function and Pathology 10
- CRISPR and Genetic Engineering 8
- Circular RNAs in diseases 6
- Aging top 5%
- Oncology top 5%
- CAR-T cell therapy research 7
- Co-authors
- Ming O. LiNa YinSharon B. CantorKe XuSagar ChhangawalaChristina S. LeslieChangdong LiuAlan M. Laties
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Min Peng
88 papers receiving 4.6k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Cancer Research 833
- Immunology 1.0k
- Molecular Biology 3.1k
- Aging 78
- Oncology 777
Countries citing papers authored by Min Peng
This map shows the geographic impact of Min Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Peng more than expected).
Fields of papers citing papers by Min Peng
This network shows the impact of papers produced by Min Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Peng. The network helps show where Min Peng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 21 | |
| 5 | 2024 | 14 | |
| 6 | 2023 | 23 | |
| 7 | 2023 | 2 | |
| 8 | 2022 | 7 | |
| 9 | Glycolysis fuels phosphoinositide 3-kinase signaling to bolster T cell immunitybreakdown → | 2021 | 252 |
| 10 | 2021 | 33 | |
| 11 | 2017 | 14 | |
| 12 | Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanismbreakdown → | 2016 | 599 |
| 13 | 2015 | 56 | |
| 14 | 2013 | 24 | |
| 15 | 2013 | 11 | |
| 16 | 2011 | 15 | |
| 17 | 2011 | 42 | |
| 18 | 2010 | 18 | |
| 19 | 2009 | 7 | |
| 20 | 2005 | 27 |
About Min Peng
Min Peng is a scholar working on Cancer Research, Clinical Biochemistry and Immunology, having authored 94 papers that have together received 4.6k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (14 papers), Immune Cell Function and Interaction (11 papers), Mitochondrial Function and Pathology (10 papers), CRISPR and Genetic Engineering (8 papers), T-cell and B-cell Immunology (7 papers), CAR-T cell therapy research (7 papers), MicroRNA in disease regulation (6 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (833 citations), Immunology (1.0k citations) and Molecular Biology (3.1k citations). Min Peng has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Ming O. Li, Na Yin, Sharon B. Cantor, Ke Xu, Sagar Chhangawala, Christina S. Leslie, Changdong Liu, Alan M. Laties, Rong Wen and Jenny Xie. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.